KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹17 Cr | ₹18 Cr | ₹20 Cr | ₹41 Cr | ₹21 Cr |
What is the latest Contingent Liabilities ratio of KOPRAN ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹17 Cr |
Mar2024 | ₹18 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹41 Cr |
Mar2021 | ₹21 Cr |
How is Contingent Liabilities of KOPRAN Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹17 Cr | -5.24 | |
Mar2024 | ₹18 Cr | -9.05 | |
Mar2023 | ₹20 Cr | -51.22 | |
Mar2022 | ₹41 Cr | 93.30 | |
Mar2021 | ₹21 Cr | - |
Compare Contingent Liabilities of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹874.7 Cr | 13.7% | 14.3% | -43.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹379,191.0 Cr | 1% | -0.9% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,973.0 Cr | -1.6% | -1.8% | 17.9% | Stock Analytics | |
CIPLA | ₹124,507.0 Cr | -1.8% | 3.7% | -6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,175.0 Cr | 0.7% | 2.4% | 3.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,355.0 Cr | -0.6% | 4.5% | -6.5% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | 13.7% |
14.3% |
-43.7% |
SENSEX | 0.5% |
0.1% |
-2.1% |
You may also like the below Video Courses